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Abstract
We present the hypothesis that an accumulation of dysfunctional mitochondria initiates a signaling
cascade leading to motor neuron and muscle fiber death and culminating in sarcopenia.
Interactions between neural and muscle cells that contain dysfunctional mitochondria exacerbate
sarcopenia. Preventing sarcopenia will require identifying mitochondrial sources of dysfunction
that are reversible.

Graphical abstract
Author Manuscript

Summary for TOC: Sarcopenia is characterized by fiber atrophy and loss of fibers. Mitochondria
health determine death signaling leading to localized protein loss and if unchecked, widespread
loss of muscle fibers.
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Introduction

Author Manuscript

Sarcopenia, is associated with increased levels of apoptosis (47) and reduced capabilities for
muscle regeneration (41) leading to muscle wasting. For this reason, many studies including
our own have focused on the muscle specific signaling that contribute to muscle wasting in
sarcopenia. However, sarcopenia in aged humans and rodents is also associated with motor
neuronal death (96, 139), which causes impaired innervation (48, 106), and a ~27%
reduction in the motor unit pool. In aging, a loss of innervation induces profound muscle
atrophy (5, 106, 129). Some denervated fibers become innervated by axons from surviving
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motor neurons (42, 45), whereas other fibers remain denervated and contribute to functional
losses in sarcopenia (42).
We postulate that the tight relationship between the loss of motor neurons and muscle cells
in aging is explained by a common underlying mechanism that initiates deterioration in
these cells. It is interesting that a loss of mitochondria function with aging is a mechanism
that is shared by both muscle cells (18, 63) and motor neurons (123). Our current
perspective and hypothesis is that mitochondrial deterioration in muscles and motor neurons
is the primary initiator of sarcopenia (Figure 1). We have identified some of the data that
support this perspective, and the areas that are speculative and require additional work to test
this hypothesis.
Mitochondrial regulation of sarcopenia - Hypothesis

Author Manuscript

Aging increases mitochondrial stress that sensitizes the opening of the mitochondria
transition permeability pore (mPTP). A loss of mitophagy-proteasome-induced
mitochondrial clearance in muscle and motor neuron cells promotes accumulation of poorly
functioning mitochondria that have increased mPTP opening. Leakage of the mitochondrial
contents to the cell cytosol initiates death (apoptosis) signaling in muscle cells and motor
neurons, which contributes to nuclear DNA fragmentation and if not repaired, nuclear
apoptosis. Removal of nuclei in muscle cells and motor neurons leads to fiber and motor
neuron death and loss of innervation to the muscle cells. Cross talk between muscles and
motor neurons that contain dysfunctional mitochondria exacerbates sarcopenia. Thus,
mitochondria are key initiators and regulators of sarcopenia (Figure 1).

Author Manuscript

Sources for mitochondrial damage in aging muscles and motor neurons—Our
working hypothesis is that sarcopenia is initiated by an aging-associated insult to
mitochondria in muscle cells and motor neurons. Mitochondrial stress in aging can originate
from greater levels of oxidants, DNA damage, or denervation (31, 133).

Author Manuscript

Reactive oxygen species (ROS) induced damage—Aging increases ROS
production (22), and lowers antioxidant enzymes levels in muscle and neuron cells (58, 59,
121). ROS production might be secondary to denervation that occurs in muscles from old
animals or humans (48, 55, 133). The accumulation of ROS has the potential to damage
cellular mitochondria (reviewed in (15)). The importance of antioxidants in sarcopenia is
highlighted by observations that both neural and muscle losses of the cytosolic antioxidant
CuZn-superoxide dismutase (CuZnSOD) recapitulated sarcopenic muscle loss in a mouse
model (125). It is noteworthy that the absence of CuZnSOD in either neural or muscle cells
did not manifest full sarcopenic muscle loss (125). However, this observation highlights the
need to consider cross talk between these two tissues in aging. Whatever the initial source(s)
of ROS production, it is clear that accumulation of excessive ROS contributes to damaged
and dysfunctional mitochondria in muscle and neural cells.
Mitochondrial DNA damage and aging in motor neurons and muscle cells—
Mitochondrial DNA (mtDNA) deletions or DNA mutations contribute to mitochondrial
dysfunction and aging-related muscle fiber loss and atrophy (50, 90). In neurons, DNA
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damage precedes neuronal apoptosis (85), whereas forced repair of DNA damage rescues
neurons from elimination by apoptosis (86). Indeed, increased mtDNA mutations have been
found in fiber regions that contain oxidative damage (2, 90). Furthermore, aging-induced
mtDNA deletions are closely associated with a loss of mitochondrial function in motor
neurons (123), neuronal malfunction in diseases like Parkinson’s disease (115), and muscle
loss with aging (50, 91). While elevated ROS production is not solely the result of mtDNA
deletions or mtDNA mutations (141), it is clear that this mechanism contributes to
mitochondrial ROS production in aging muscles and neurons (26, 86, 91).

Mitochondria permeability transition pore sensitization with aging –
mitochondrial dysfunction
Author Manuscript

Stress-induced damage to mitochondrial membranes (40, 108, 144, 147) contributes to
sensitization of the mitochondrial permeability transition pore (mPTP) (44). The mPTP is a
large conductance pore in the inner mitochondrial membrane, which is predominantly closed
under non-stressed conditions. Opening of the mPTP can be induced by ROS, increased
concentrations of Ca2+, or mitochondrial depolarization. mPTP opening is further
exacerbated by an imbalance of Ca2+ homeostasis that likely results from leaky ryanodine
receptors in aged skeletal muscle (10). Excessive Ca2+ loading leads to mitochondrial
swelling, and rupture of the outer mitochondrial membrane.

Author Manuscript

Opening the mPTP induces a further loss of mitochondrial membrane potential, and releases
the mitochondrial contents to the cytosol to initiate apoptotic signaling (24, 77, 89).
Apoptosis signaling has been reported in muscle and neuronal cells of aged rodents (4, 7, 26,
34, 47, 77, 88, 130), and humans (44, 145). Aging-associated muscle denervation may also
contribute to increased mPTP opening, that in turn induces apoptosis and muscle loss (76,
133).
Similar to skeletal muscle cells, ROS damage to mitochondria in neurons from aged animals
contributes to mPTP opening (53). This occurs through p66Shc which generates H2O2 that
in turn, reacts with cytochrome c and induces oxidation of the mPTP and mitochondrial
swelling (126). This mechanism is similar to neural degenerative diseases where induction
of ROS (80, 113) contributes to motor neuron death (116). Thus, mitochondrial
susceptibility to mPTP opening is a common point which triggers downstream cell
destruction in both neuron and muscle cells.

Insufficient mitophagy allows unhealthy mitochondria to persist in aging
Author Manuscript

muscles and neurons
Damaged mitochondria normally undergo fission then they are finally removed by
mitophagy. However, mitophagy is attenuated with aging in skeletal muscle and motor
neurons (40, 63, 70, 127). AMP-activated protein kinase (AMPK) and Sirtuin 1 (SIRT1)
trigger the destruction of dysfunctional fragmented mitochondria through FoxO3-dependent
autophagy (mitophagy) (94, 118). Mitofusin 2 (Mfn2) has an important role regulating
mitochondrial fusion, but it also acts a receptor for Pink1 and Parkin-targeted mitophagy
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(27). Recent data by Sebastián and colleagues (127) show that Mfn2 declines in muscle with
aging and loss of Mfn2 produces an aging-like phenotype, including age-associated
mitochondrial dysfunction, higher ROS accumulation and muscle fiber atrophy. Mfn2 has
also been implicated in the loss of mitophagy in motor neurons. For example, a reduced
inhibition of the E3 ligase Omi/HtrA2 in neuronal mitochondria contributes to a decrease in
Mfn2 leading to attenuated mitophagy (29). Thus, an aging associated deficiency of Mfn2
may be the bridge between impaired mitophagy and an accumulation of dysfunctional
mitochondria in muscle and neurons during sarcopenia. However, it should be pointed out
that other evidence does not support a decrease in Mfn2 or a decrease in the Mfn2 to Drp1
ratio that would be expected if Mfn2 were suppressed in muscles of aged mice (75).

Author Manuscript

Defective mitophagy underlies the progression of motor neuron death in Amyotrophic
lateral sclerosis (ALS) (38). In contrast, lithium-induced induction of mitophagy (38, 101)
and mitochondrial biogenesis (101) improves mitochondrial morphology in motor neurons
of a G93A SOD-1 mouse model of ALS. Other autophagy proteins, including Pink152,
which is the cleavage product of the mitochondrial autophagy protein Pink1, has been
implicated in the attenuation of mitophagy in motor neurons. Pink152 can exit the
mitochondria in neuron cells and cleave Parkin, which then suppresses its translocation to
the mitochondria to attenuate mitophagy (36).

Author Manuscript

Contrary data suggest that mitophagy may be increased in aging muscles as evidenced by
greater migration of Parkin and p62 to the mitochondria (103). Nevertheless, an
accumulation of lipofuscin granules suggests a failure of the lysosome to remove
dysfunctional mitochondrial in aging even when Parkin has translocated to the mitochondria
(103). Indeed, lipofuscin deposits have been reported previously in many tissues including
muscles and neurons of aged rodents or other mammals (138). Further work is needed to
determine if lysosomal dysfunction (136), loss of Mfn2, or some other protein involved in
mitochondrial dynamics regulates mitophagy in sarcopenia.

Local apoptotic signaling in aging muscles and motor neurons becomes
more wide spread to result in cell death

Author Manuscript

Our hypothetical model to explain the loss of single muscle fibers in sarcopenia is shown in
Figure 2. This model assumes that local mitochondrial damage (potentially via ROS, high
calcium loads, mtDNA damage etc.) causes increased mPTP opening, which triggers the
contents of the mitochondria to leak to the cytosol. This initiates the intrinsic apoptotic
signaling pathway leading to DNA fragmentation and nuclear apoptosis in a localized region
of the fiber. An aging-suppression of autophagy activators like Sirtuin 1 (SIRT1) and Mfn2
or other proteins involved in mitophagy, prevents removal of dysfunctional mitochondria via
mitophagy and proteasome digestion.
The regional accumulation of damaged mitochondria could extend to other regions within
the fiber via their connecting reticular network. As dysfunctional mitochondria accumulate,
the region of the fiber that is engulfed by death signaling is expanded. We predict that
eventually the entire fiber would be eliminated, presumably by involving the proteasome.
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Genes of necrosis may also contribute to the overall cellular removal as sarcopenia
progresses (26).
Cardiolipin is an important mitochondria-specific phospholipid, which is concentrated
between inner and outer mitochondrial membranes, and redistribution of cardiolipin leads to
a localized oligomerization of proapoptotic proteins (83). A local apoptotic cascade could
occur via restricted remodeling and redistribution of cardiolipin adjacent to dysfunctional
mitochondria. Furthermore, interaction of cardiolipin with the structural protein vimentin
(104) could provide a localized cell-signaling site for targeted apoptotic disassembly and
removal via anti-vimentin/CL complex antibodies, as has been observed in several
pathologies involving apoptosis (104).

Author Manuscript
Author Manuscript

Our model for a localized apoptotic and proteolytic signaling cascade that expands to
neighboring regions of a muscle fiber (Figure 2) has strong support from the work of Aiken
and co-workers (26, 49, 50). For example, Cheema et al. (26) observed a localized aginginduced loss of the mitochondrial enzymes succinate dehydrogenase and cytochrome c
oxidase. Interestingly, the same fiber region that had mitochondrial disruption was both
atrophic and had high levels of the apoptotic protein caspase-3. In contrast, fiber atrophy and
apoptotic signaling did not occur in other regions of the same muscle fibers that were
located further away from the dysfunctional mitochondrial (26). If the degenerative
processes were not initiated locally but rather from a more general or systemic source, we
would expect uniform muscle fiber wasting across its length, but this is not the case.
Nevertheless, we predict that the progression of sarcopenia involves a gradual shift from
targeted proteins in regions close to dysfunctional mitochondria to a strategy of non-targeted
cellular destruction by activating the proteasome pathway when the apoptotic signaling
expands to a wider fiber area.

Author Manuscript

We recognize that mitochondria are represented as distinct organelles in this simplistic
model of localized signaling shown in Figure 2. However, mitochondria can range from
small individual organelles, to rather extensive and connected reticular systems (57). In our
model, mitophagy would be expected to target the regional area near dysfunctional
mitochondria via the Pink1/Parkin and the LC3-II/autophagy receptor system for lysosomal
removal. Although speculative, it is possible that elimination of a section of dysfunctional
mitochondria could occur without disruption to the entire network of mitochondria along its
reticulum. This could occur by activating fission signaling to wall off a healthy region of the
mitochondrial reticulum from a region of dysfunctional mitochondria. Indeed, increased
mitochondrial fission dynamics have been reported after muscle denervation (57) and in
aging (55, 62). On the other hand, insufficient mitophagy in muscles from very old hosts
could permit mitochondrial dysfunction in one area to affect other regions along the same
mitochondrial reticulum and therefore affect a wider region of the cell.
We speculate that similar to our model in skeletal muscle fibers, motor neurons in aging
hosts have increased mPTP opening, leading to apoptotic signaling, but dysfunctional
mitochondrial are not removed because mitophagy is suppressed in aging. The apoptotic
disassembly of motor neurons could begin regionally near dysfunctional mitochondria and
spread to a wider area, resulting in motor neuronal death. Our speculation is supported from
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data that show that in aging-associated neural diseases, there is a loss of mitochondrial
function leading to increased mPTP sensitivity, and attenuated mitophagy that contributes to
apoptosis (32, 68, 86, 99, 111). Nevertheless, we do not have data to support a process of
aging associated localized motor neuron disassembly outside of neural degenerative disease.
Additional work is needed to determine if localized loss of mitochondrial function
contributes to a regional concentration of apoptotic signaling in motor neurons in the same
way that it might occur in skeletal muscle cells with aging.
Altered mitochondrial dynamics with aging

Author Manuscript
Author Manuscript

Abnormal mitochondrial dynamics may negatively affect mitochondrial health. For example,
both the mRNA level and the protein abundance of important fusion and fission proteins
have been reported to be lower in old as compared to young adult skeletal muscle (55), and
this would suggest that the potential for mitochondria to respond to changing environments
might be reduced as compared to mitochondria from young hosts. Indeed, this appears to be
the case, because electron microscopy and biochemical analyses have shown small, more
fragmented mitochondria in muscles from old as compared to young adult hosts (56, 57),
although very large mitochondria have also been noted in muscles from old animals (75).
Consistent with the fragmented mitochondrial phenotype in muscles from old hosts, there is
evidence to suggest that muscles of aged rodents and humans have a greater overall rate of
fission vs. fusion (55, 62) and lower levels of the fusion protein Opa1 (62) as compared with
younger muscles. Fragmented mitochondria tend to have a lower respiratory capacity, and a
greater production of ROS, which increases the susceptibility of mitochondria to release its
contents and activate the intrinsic caspase apoptotic pathway. Thus, it is not surprising that
aging and disuse, which both have excessively fragmented mitochondria, are accompanied
by muscle loss (57). It is interesting that a knockout of Mfn 1/2 in skeletal muscle, which
prevented mitochondrial fusion, increased the accumulation of mtDNA defects and resulted
in muscle atrophy (31). Together, these observations support for the idea that muscle
mitochondria are important regulators of muscle size. However, to provide a balanced
perspective it is important to point out that other studies have found higher fusion profiles in
muscles of humans (14), and prematurely aged mice (63), and larger mitochondria in
muscles of old mice (75). It is interesting that studies that have reported a higher fusion
index in muscles from old rodents as indicated by ratios of Mfn1/Mfn2 (63) or Mfn2/Drp1
(75) did not find changes in the protein contents of Mfn1, Mfn2, Opa1 or Drp1. Thus, even
when higher fusion indexes are recorded there still may be more fragmented mitochondria in
aged muscles

Author Manuscript

The impact of age-associated changes in the mitochondrial dynamics of motor neurons and
their potential role in sarcopenia have not been studied. However, dysfunction of
mitochondrial dynamics has been reported as an early event in Amyotrophic lateral sclerosis
(61) which is a common motor neuron disease. Furthermore, increased mitochondrial
fragmentation has been found to precede glutamate-induced death of motor neurons (143).
Thus, similar to mitochondrial dynamic changes that have been proposed in muscle with
aging, motor neuron dysfunction and death may converge upon mitochondria, and
mitochondrial dynamics may play an important role in regulation of neuronal function that
contributes to accelerated sarcopenia.
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FOXO proteins and the ubiquitin proteasome system (UPS) in muscle
atrophy and sarcopenia

Author Manuscript

An acceleration of protein turnover with a net loss of protein is downstream of dysfunctional
mitochondria but this represents a major contributor to sarcopenia. AMPK activation (118)
and the Forkhead box class O (FOXO) transcription factor family regulates the ubiquitin
proteasome system (UPS), and the autophagy-lysosome system. FOXO proteins also
regulate the UPS, which is a tightly regulated system responsible for normal intracellular
protein turnover and elimination of misfolded and dysfunctional proteins (72, 74). FOXOs
control the mammalian target of rapamycin complex 1 (MTORC1) signaling, which is
associated with muscle hypertrophy (43) and inhibition of mitophagy in skeletal muscle
(23). FOXO regulation also occurs by MTORC1-mediated phosphorylation of ULK1 at
Ser757 and the subsequent activation of the ULK1-ATG13- RP6KB/ribosomal protein
p70S6 kinase (RB1CC1) in the UPS (23). Inhibition of MTORC1 in muscles of tuberous
sclerosis complex (TSC) knockout mice, mimic many features of aging. This includes a loss
of muscle mass and strength and attenuated mitophagy (23). However, protein turnover is
tightly controlled because MTORC1 is upregulated in denervation-induced muscle atrophy
(135). Interestingly, inhibition of MTORC1 reduced muscle atrophy via suppression of E3
ligases, Muscle RING Finger 1 (MuRF1) and MAFbx/atrogin in response to denervation
(135).

Author Manuscript

FOXO control of the UPS is important in the final steps of degradation of proteins in
sarcopenia. FOXOs activate lysosomal cathepsins and cytosolic protease calpains which
progresses towards ATP-dependent UPS activation via FOXO3a associated MuRF-1 and
MAFbx regulation [reviewed in (66, 117)]. Thus, FOXO mediated autophagy via the UPS
may be an important regulator of muscle mass in aging. In future studies it will be important
to determine if failure to regulate FOXO control of MTORC1 or perhaps failure of other
proteins that are in the pathways of anabolism might contribute to increased degradation of
muscle proteins in aging.

Author Manuscript

Conflicting data highlight the complexity of understanding the importance of the UPS and
atrogenes in sarcopenia. For example, ubiquitin (17), 26S proteasome, poly-ubiquitinated
proteins (3), MuRF-1 and MAFbx expression were all reported to be elevated in hindlimb
muscles of sarcopenic rats as compared to young adult animals (3, 30). Furthermore,
ubiquitin was found to be greater in quadriceps muscles of older (70-79 yrs old) human
subjects as compared to young adults (20-29 yrs old) (17). In contrast, MuRF-1 and MAFbx
expression were reported to be lower in muscles of old rats than young adult rats (35) and
not changed with aging in vastus lateralis of humans (145). The discrepancy between these
studies might be due to variability introduced by a low number of subjects or animals in
each study, and perhaps by some differences in the age and sex of the subjects that were
studied. It is also possible that activity, nutritional history, health and smoking habits etc.
will have affected MuRF-1 and MAFbx regulation in these studies. Thus, additional studies
are warranted to understand the importance of the UPS in sarcopenia and the role of
mitochondria in regulating the UPS more fully.
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UPS disruption increases dysfunctional mitochondria in muscle and neural cells

Author Manuscript

Aging associated neural diseases like Parkinson’s and Alzheimer’s disease, are associated
with high ROS levels in neural cells. Reduced mitophagy associated Pink1- and Parkinregulated ubiquitination of the outer mitochondrial membrane of damaged mitochondria in
aged neurons (79, 99, 140) contribute to a greater accumulation of ROS (81). High ROS can
damage more mitochondria in muscle and neurons (81) and potentially elevate ROS levels
even higher. It is therefore likely that proteasome dysfunction contributes to the higher
potential for ROS generation in muscles and neuron cells of older individuals or animals.

Author Manuscript

An association between the UPS and mitochondria occur through a splice variant of the
master mitochondrial regulator peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1α). PGC-1α2, PGC-1α3, and PGC-1α4, have been shown to
stimulate protein synthesis and attenuate UPS activity in cultured myotubes and mouse
skeletal muscle (87, 119). Furthermore, PGC-1α reduces muscle protein degradation by the
UPS via blocking nuclear factor κB (NF-κB) and FoxO3 activity (16, 124).
Cross talk between mitochondrial regulators of autophagy and the UPS

Author Manuscript

There is considerable communication between the UPS, mitochondrial regulators and
governors of autophagy. For example, silent mating type information regulation 2 homolog 1
(SIRT1) appears to be part of a pathway that regulates mitophagy. This pathway also
involves AMPK, a master energy sensor (20). AMPK increases NAD+ levels, which
activates NAD+-dependent SIRT1. Activated SIRT1 deacetylates and activates PCG-1α
which promotes mitochondria synthesis, assembly, growth and mitochondrial antioxidant
production (54). Deacetylation of FOXO1 and FOXO3a by SIRT1 (19, 20) mediates
autophagic signaling in muscle cells, and aging attenuates SIRT1, which reduces autophagy
(134). Furthermore, overexpression of SIRT1 reduces muscle wasting and innervationinduced muscle atrophy by deacetylation and inhibiting FOXO1a and FOXO3 thereby
inhibiting induction of MuRF-1 and MAFbx. Future studies should establish the relative
importance of cross talk between PGC-1α, FOXO, SIRT1 and the UPS in aging muscles and
motor neurons and establish how this affects sarcopenia.
Communication between mitochondrial induced death signaling in muscle and motor
neuron cells accelerate cell death in aging

Author Manuscript

Cross talk between muscle and motor neurons are important to both tissues. This has been
known for several decades, because when toxins or other compounds are injected into
muscles, the compounds undergo retrograde transport to the neuromuscular junction (105),
deposit in motor neurons (11), and sometimes contributes to motor neuronal dysfunction
(reviewed in (33, 39). This communication is also seen when spinal cord injury or
denervation induces large-scale muscle wasting (57, 76, 107, 129, 131, 137), and
denervation is a condition often seen as part of sarcopenia. High levels of apoptotic signaling
(1, 129) and altered autophagy signaling (102, 103) with elevated UPS activity (137) occurs
in muscles after spinal cord injury or denervation. Thus, we would expect that altered
neuronal signaling is due at least in part to high ROS production and mitochondrial
dysfunction in the muscle cells, and conversely, that neural dysfunction will be
communicated to muscle cells (57, 100).
Exerc Sport Sci Rev. Author manuscript; available in PMC 2018 April 01.
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The health of muscle cells also affects motor neuron health. For example, increased muscle
activity in male G93A SOD1 deficient mice contributes to greater motor impairment and
motor neuron accelerated death (82). This implies that a feedback loop exists that conveys
information about muscle activity and the condition of the muscle to the motor neuron.
Further evidence of a muscle to motor neuron feedback pathway is supported from data
showing increases in mitochondrial succinate dehydrogenase (SDH) activity in motor
neurons following functional overload of the plantaris hindlimb muscle in cats (25).
Furthermore, the presynaptic motor endplate of the neuromuscular junction is critical for
providing retrograde transport to the motor neuron (98).

Author Manuscript
Author Manuscript

Observations from aging rats suggests that mitochondria in the axon terminals of the
neuromuscular junction undergo swelling, in part from calcium overload. The resulting
dysfunction of mitochondrial metabolism and dynamics contributes to elevations in cytosolic
cytochrome c and caspase-3 (39). Furthermore, inhibition of synaptic loss reduces apoptosis
of motor neurons in a mouse model of motor neuron disease (37). Together, these
observations confirm that the same mitochondrial-induced initiation of apoptosis signaling
that occurs in skeletal muscle also occurs in neuromuscular junctions with aging. We
speculate that in aging, motor neurons receive feedback from deteriorating muscles and
neuromuscular junctions and this communication in turn feeds to a loop of accelerated
mitochondrial-induced degenerative changes in motor neurons. Although we cannot rule out
the possibility that mitochondrial-induced apoptotic signaling and cell death may occur
independently in muscle and motor neuron cells in aging, we have illustrated potential
general feedback routes between muscle and motor neuron comparts that may affect the
other tissue type, and if this occurs, we would expect sarcopenia to be accelerated (Figure
1). Clearly, additional studies are need to test for the presence of these potential
communication loops in aging.
Perspectives for Future Progress and the need for Future Studies

Author Manuscript

Our hypotheses is based on some speculation and therefore additional work is needed to test
these hypotheses. Even if the mitochondrial centered hypothesis for sarcopenia is true, there
are unknown factors that would be important to study in order that the information can make
a practical impact on sarcopenia. A few of these questions are: As mitochondria damage
may occur in several different ways (e.g., ubiquination, acetylation, succinylation, ROS
damage to inner membrane, mtDNA damage, etc.), which of these (or other pathways) are
the most important to sensitize mPTP opening to trigger apoptosis? What is the best strategy
to combat mitochondrial dysfunction in aging? If exercise is considered to be a tool for
reducing mitochondrial dysfunction, how would exercise target dysfunctional mitochondria?
Is it necessary for muscle and neuron cells to improve mitochondria number or just remove
dysfunctional mitochondria to slow or prevent sarcopenia? These questions are explored
below, but the lack of clear information emphasizes the need for additional studies to
provide these answers.
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What is the most important source of mitochondrial damage that triggers apoptosis and
cell death?
We have focused on ROS damage to the inner mitochondrial membrane (15, 21, 22, 79) and
mtDNA damage (22, 26, 50, 63, 73) as two important ways that might impair mitochondrial
function in aging muscles and motor neurons. However, mitochondria damage and
modifications may also occur by posttranslational modifications such as ubiquitination (67,
99, 140, 148), acetylation (9, 21, 28), succinylation (114, 150), and phosphorylation (51, 73,
79). Other potential sources of mitochondrial damage include excessive calcium loading (9,
28). Likely some damage is repairable, whereas other damage contributes to irreparable
mPTP opening leading to nuclear apoptosis and cell death. It is important to identify which
of these (or other pathways) provide potential reversible mitochondrial damage and which
cause irreversible damage that promotes apoptosis.

Author Manuscript

Potential strategies using exercise and nutrition to reduce sarcopenia should focus on
mitochondrial health

Author Manuscript

Exercise interventions and nutritional manipulations have produced some successes for
reducing although not fully eliminating sarcopenia. A logical place to begin the search for
ways by which exercise and nutritional approaches might better attenuate sarcopenia is by
targeting these strategies to maximize mitochondria health. This includes identifying the
mitochondrial modifications that are reversible by exercise and nutritional interventions in
aging. For example, mitochondrial acetylation is reversible at least under some
circumstances including exercise (97). Proteins like SIRT1 and SIRT3 may be important
regulators of deacetylation in mitochondria (46, 97, 132). SIRT1 is important for
deacetylation of mitochondrial-interacting targets like PGC-1α, FOXO3, p53 and NF-kB
(Reviewed in (13, 110) and has been implicated in improving function and life span in aging
(95). Furthermore, SIRT1 deacetylation of Mfn2 may be important for regulating mitophagy
and removing dysfunctional mitochondria (132). In addition, evidence from non-muscle and
non-neuronal cells suggests that mPTP-mediated pore opening and apoptosis can be
inhibited by deacetylation of mitochondria by SIRT3 (46).

Author Manuscript

Exercise training and nutrition could be used as an intervention to increase SIRT1 and
SIRT3 activity with the goal of increasing mitophagy and mitochondrial biogenesis
pathways in muscle and neuronal cells. However, aging is associated with high cell levels of
ROS and ROS accumulation is an inductor for mPTP opening. ROS accumulation could
increase with exercise, and this may be why exercise has only been partially successful in
reducing sarcopenia. We postulate that nutritional regulation of oxidants should be
considered to minimize the additional ROS burden (58, 59, 120-122) when initiating
exercise training in the elderly to minimize mPTP opening. Future studies could test if
nutritional antioxidants would minimize excessive ROS accumulation, oxidant damage and
mPTP opening in muscles and neurons when elderly persons begin an exercise program. If
this were the case, we would predict that antioxidant supplements should be slowly reduced
after some duration of training adaption has past, to permit cellular increases in SIRT1/
SIRT3 and antioxidant defenses for the elderly subjects without risking excessive ROS
damage.
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How might exercise target dysfunctional mitochondria by mitophagy?
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Studies in rodents have shown an increased abundance of autophagy proteins including Drp1
and Bcl-2 and 19 kDa interacting protein-3 (Bnip3) after exercise (60, 65, 71, 78). Bnip3
functions as a mitophagy receptor to recruit selected autophagosomes for elimination.
Exercise-induced Pink1 activation of Drp1 (112) could also target dysfunctional
mitochondria for mitophagy. This idea is supported by recent data from Mejias-Pena et al.
(92) who found an increase in the protein abundance of autophagy proteins Beclin-1, Atg12,
Atg16, and the LC3II/I ratio in blood mononuclear cells of elderly subjects after 8 weeks of
aerobic exercise. Furthermore, 8 weeks of aerobic exercise has been reported to increase
autophagy proteins Beclin-1, ATG7, and MuRF-1 in muscles of old mice (70). Indeed, it has
been proposed that autophagy signals are necessary to achieve aerobic improvements in
skeletal muscle (78). Thus, autophagy proteins may be important for an exercise-mediated
slowing of sarcopenia. If the same processes occur in humans as is the case in rodents and
non-human mammals (64), exercise, or nutritional intervention such as caloric restriction
would also be expected to increase mitophagy removal of dysfunctional mitochondrial, so
the mitochondria that remain are proportionally healthier (64).

Author Manuscript

Although clearly speculative, we postulate that in response to exercise or nutritional
interventions, mitochondria that are the most dysfunctional would provide the greatest
magnitude of apoptotic signaling and be more likely to attract autophagy linker proteins
(e.g., p62) for elimination by mitophagy. Future studies are needed to identify the precise
signatures of local death signaling around individual dysfunctional mitochondria and to
determine which autophagy receptors are reduced by exercise or nutritional interventions
and to examine if activated LC3-II is attenuated or eliminated once dysfunctional
mitochondria are removed. This will take technology that is able to identify dysfunctional
from healthy mitochondria and sample the milieu adjacent to each mitochondria.
Although speculative, exercise or nutritional modifications might target dysfunctional
mitochondria for elimination is via an autophagy pathway called chaperone-mediated
autophagy (CMA). CMA involves the binding of constitutive heat shock 70 to selected
proteins, which are targeted to the lysosomal membrane where they interact with membrane
receptor lysosomal-associated membrane protein 2A (LAMP2A). Aging causes degradation
and availability of LAMP2A in the lysosomal membranes (69), which reduces the
effectiveness of CMA. Future studies should evaluate the role of LAMP2A and determine if
exercise or nutritional interventions increase CMA and target dysfunctional mitochondrial
for mitophagy in muscles and motor neurons of old animals or humans.
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Another potential way that exercise could selectively target dysfunctional mitochondria is
through elevation of Parkin or the degradation of PARK7/DJ-1 (142). PARK7 is an
antioxidant protein that limits mitochondrial damage in response to oxidative stress (12) and
it regulates skeletal muscle contractile protein synthesis and hypertrophy (149).
Overexpression of PARK7 reduces mitochondrial dysfunction under oxidative stress (142)
which shows a direct link between autophagy and mitochondrial function. Future studies
should identify if exercise or nutritional intervention (e.g., antioxidants, caloric restriction)
improves PARK7 expression in muscles and motor neurons of old hosts and if the change in
PARK7 directly mediates improvements in mitochondrial function of skeletal muscle.
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Parkin and Pink1 are attractive candidates for targeting dysfunctional mitochondria, which
we speculate would occur in response to exercise. This is because accumulation of Pink1 at
the outer mitochondrial membrane provides a precise mechanism to identify dysfunctional
mitochondria from healthy ones. Pink1 promotes Parkin recruitment to activate mitophagy
and UPS signaling. However, overexpression of PGC-1α was reported to attenuate Pink1
levels in response to remobilization of muscle (67). As we would expect exercise to increase
mitochondrial biogenesis through the PGC-1α axis, it is not known if Pink1 plays an
important role in an exercise-mediated increase in mitophagy of muscle cells and motor
neurons of aged humans or rodents.
The potential role for mitochondrial biogenesis to reduce sarcopenia
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In addition to increasing mitophagy, exercise and nutritional interventions might be expected
to increase mitochondrial biogenesis and therefore replace the dysfunctional mitochondria
that are removed by mitophagy. Both endurance and resistance exercise have been associated
with elevated mitochondrial biogenesis (93, 109). Relative mitochondrial activity
corresponds with fractional protein synthesis rates, because many proteins complete their
translation at mitochondria (84). There is an assumption that endurance and strength training
by older adults induces mitochondrial biogenesis, but given the propensity for mtDNA
damage and high ROS levels in aging, this remains uncertain. If newly synthesized
mitochondria were generated in exercised muscles and motor neurons from aged hosts, but
the new mitochondrial were unhealthy (e.g., incompletely folded proteins), the mitophagy
signals (from exercise or nutritional interventions) would need to be even higher to remove
these newly formed but dysfunctional mitochondria. Clearly, additional work is needed
before we fully understand if exercise or nutritional interventions synthesize completely
functional and healthy mitochondria in aged hosts, or if the basal environment of oxidative
stress etc. results in a new population of unhealthy mitochondria that must also be targeted
for mitophagic removal in the elderly.
We know that exercise downregulates apoptosis and upregulates mitophagy (4, 52, 128,
146). Nevertheless, future studies should explore the mechanisms by which exercise
activates mitophagic, and attenuates apoptotic, and necrotic signaling pathways in muscle
cells and motor neurons of older individuals (4, 47). We recognize that increased apoptosis
and reduced mitophagy have not been identified as an aging-related condition in every study,
but in our view, there is sufficient data to suggest that this is probably an underlying process
for most cells in aging. Nevertheless, some of the mitochondrial mediated pathways leading
to motor neuron death in aging have not received much attention and should be the
investigation of future work.
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Future experiments should also identify novel proteins and protein functions that better
define the communication of dysfunctional signaling between motor neurons and muscle
cells in aging. Modern genetic approaches, including RNA-seq and proteome pathway
analysis, will likely be required. It will also be important to find out if it is possible to
reverse the process responsible for regional disassembly in the absence of mitochondrial
biogenesis, and then to focus on molecular events and targets in muscle and motor neurons
that are upstream of this point. In the quest to attenuate sarcopenia, it will also be important
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to understand the limit for mitochondrial health to impact satellite cell function for repairing
and replacing sections of fibers or whole fibers, as satellite cells are affected adversely by
aging, mitochondrial damage and death signaling (4, 6, 7, 144).

Conclusions
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Mitochondrial-regulated apoptosis provides a strong signaling network that contributes to
sarcopenia (8). We have taken the perspective that both neural and muscle components
contribute to muscle wasting but mitochondrial health is central to initiating and
perpetuating the signal for sarcopenia. We argue that mitochondrial dysfunction leads to
increased mPTP opening and initiates apoptotic signaling in muscle cells and motor neurons.
In aging, this is not corrected because mitophagy is inhibited. Proteasome activation leads to
removal of cellular contents close to the site of dysfunctional mitochondria, and this cellular
dismantling expands proportionally to the accumulation of dysfunctional mitochondria.
Although aging induces wide spread systemic mitochondrial dysfunction, perhaps as a result
of high ROS or accumulation of mtDNA damage, we have considered that retrograde and
anterograde communication likely exists between dying muscle and motor neurons, which
may accelerate death in both compartments.
Additional studies are needed to establish if exercise and nutrition can be used to effectively
improve mitochondria health and reduce sarcopenia in aging populations. In our view,
targeting dysfunctional mitochondria and increasing healthy mitochondria in motor neurons
and muscle fibers provide the best strategy for reducing sarcopenia.
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•

Aging-induced mitochondrial insult in muscle and neurons (e.g., oxidative
stress, DNA damage, posttranslational modifications) results in mitochondrial
permeability transition pore opening.

•

Mitophagy signaling normally removes dysfunctional mitochondria, but this
process is impaired in aging muscle cells and motor neurons.

•

Release of the contents from dysfunctional mitochondria to the cytosol
initiates local apoptotic signaling, that if left unchecked activates nuclear
fragmentation, cell death and proteasome activation for cell removal.

•

Cross talk between dysfunctional muscle and motor neuron cells exacerbates
the sarcopenic loss of muscle mass and function.

•

To prevent sarcopenia, future studies should identify strategies that reverse
mitochondrial modifications to prevent opening of the mitochondrial
permeability pore and increase mitophagy in muscle and neuronal cells.
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Figure 1. Mitochondrial Regulated Sarcopenia
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Induction of mitochondrial stress (lightning bolt) can result in dysfunctional mitochondria.
Damaged mitochondria are engulfed in an autophagosome membrane and removed by
mitophagy signaling in healthy young muscle and motor neurons. However, aging is
associated with increased ROS and other mitochondrial stresses, which enhance mPTP
opening. Release of the mitochondrial contents to the cell cytosol induces an apoptotic
cascade ending with DNA fragmentation and removal of nuclei. Sufficient nuclear death in
muscle cells will result in the death and removal of the entire muscle cell. Similarly, motor
neuron death occurs when apoptosis removal of the alpha motor neuron nucleus occurs. The
interdependence of muscle cells and motor neurons suggests a potential feedback loop
(anterograde and retrograde) communication between the muscle and the motor neuronal
compartments, which exacerbates death in both compartments. Death in these cell
compartments leads to loss of muscle mass and function in aging. Thus, dysfunctional
mitochondria provide the signal to initiate sarcopenia.
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Figure 2. Hypothetical model for eliminating muscle fibers in sarcopenia via localized
mitochondrial associated dysfunction – mitophagy and apoptosis
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A. In healthy muscle, activation of mitophagy eliminates dysfunctional nuclei so that they
cannot continue death signaling. B. Dysfunctional mitochondria that leak their contents to
the cytosol will occur in muscle that has received a significant mitochondrial stress (e.g.,
ROS, inflammatory mediators etc.). C-D. This initiates the apoptotic signaling cascades. EF. If the dysfunctional mitochondria are not eliminated, apoptotic death signaling may be
activated to eliminate myonuclei and this may concurrently or independently result in widespread activation of autophagy and the ubiquitin ligase pathway and also, trigger the
necrosis signaling pathway to remove muscle proteins, mitochondria and nuclei within the
domain of the initial dysfunctional mitochondria (G-H). I-J. The extent of dysfunctional
mitochondrial will extend along the mitochondrial reticular network and affect the function
of other mitochondria near the dysfunctional mitochondrial. The wider accumulation of
dysfunctional mitochondria will perpetuate signaling for apoptosis, which will remove
nuclei from a larger area. The greater nuclear loss will be followed by elevated proteasome
signaling to eliminate contractile and non-contractile tissue in the fiber segment that is
associated with dysfunctional mitochondria and apoptotic signaling. This cellular removal
will result in eventual elimination of the portion of the fiber in the area of the dysfunctional
mitochondrial and potentially the entire fiber. We further hypothesize that the initiation of
the disassembly and removal of the fiber could be blocked if the dysfunctional mitochondria
which initiate the process, are removed or the damage to mitochondria reversed (e.g., via
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exercise and nutritional interventions) and if irreparable damaged mitochondria are replaced
by healthy mitochondria.

Author Manuscript
Author Manuscript
Author Manuscript
Exerc Sport Sci Rev. Author manuscript; available in PMC 2018 April 01.

